News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
697,820 Results
Type
Article (41625)
Company Profile (449)
Press Release (655746)
Section
Business (208436)
Career Advice (1998)
Deals (35953)
Drug Delivery (89)
Drug Development (83285)
Employer Resources (170)
FDA (16324)
Job Trends (15047)
News (352056)
Policy (33007)
Tag
Academia (2627)
Alliances (50601)
Alzheimer's disease (1217)
Approvals (16235)
Artificial intelligence (105)
Bankruptcy (361)
Best Places to Work (11597)
Biotechnology (333)
Breast cancer (86)
Cancer (747)
Career advice (1666)
Cell therapy (185)
Clinical research (65426)
Collaboration (266)
Compensation (146)
COVID-19 (2576)
Cystic fibrosis (82)
Data (615)
Diabetes (111)
Diagnostics (6102)
Drug pricing (80)
Earnings (85058)
Employer resources (147)
Events (111919)
Executive appointments (224)
FDA (16681)
Funding (245)
Gene therapy (136)
GLP-1 (572)
Government (4395)
Healthcare (18995)
Infectious disease (2632)
Inflammatory bowel disease (104)
Interviews (307)
IPO (16530)
Job creations (3694)
Job search strategy (1426)
Layoffs (433)
Legal (7932)
Lung cancer (140)
Manufacturing (129)
Medical device (13268)
Medtech (13273)
Mergers & acquisitions (19381)
Metabolic disorders (335)
Neuroscience (1439)
NextGen Class of 2024 (6720)
Non-profit (4539)
Northern California (1046)
Obesity (201)
Opinion (192)
Patents (86)
People (57446)
Pharmaceutical (86)
Phase I (20458)
Phase II (28864)
Phase III (21391)
Pipeline (168)
Postmarket research (2590)
Preclinical (8766)
Radiopharmaceuticals (248)
Rare diseases (171)
Real estate (6001)
Regulatory (21805)
Research institute (2406)
Resumes & cover letters (350)
Southern California (976)
Startups (3750)
United States (10710)
Vaccines (528)
Weight loss (159)
Date
Today (174)
Last 7 days (592)
Last 30 days (2739)
Last 365 days (37460)
2024 (29525)
2023 (41039)
2022 (52303)
2021 (56787)
2020 (54949)
2019 (47467)
2018 (35760)
2017 (33078)
2016 (32402)
2015 (38476)
2014 (32232)
2013 (27183)
2012 (29287)
2011 (29915)
2010 (28039)
Location
Africa (731)
Arizona (188)
Asia (38451)
Australia (6444)
California (2461)
Canada (1088)
China (185)
Colorado (100)
Connecticut (107)
Europe (83617)
Florida (343)
Georgia (82)
Illinois (299)
Indiana (168)
Kansas (98)
Maryland (480)
Massachusetts (2020)
Michigan (137)
Minnesota (244)
New Jersey (726)
New York (745)
North Carolina (689)
Northern California (1046)
Ohio (120)
Pennsylvania (687)
South America (1106)
Southern California (976)
Texas (337)
Washington State (300)
697,820 Results for "ankasa regenerative therapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Beach
Regen BioPharma, Inc. to Present at the Emerging Growth Conference on May 9, 2024
Regen BioPharma, Inc., a biotechnology company advancing a diverse pre-clinical pipeline spanning cell therapies, RNA vaccines, RNA and DNA therapeutics and small molecule drugs will be presenting at the Emerging Growth Conference on May 9, 2024.
May 7, 2024
·
3 min read
Drug Development
Our Mission at Voyager Therapeutics: Define the Future of Neurogenetic Medicines
We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system
May 8, 2024
·
2 min read
·
Voyager Therapeutics, Inc.
Biotech Beach
Regen BioPharma, Inc. to Present at the Emerging Growth Conference on March 7, 2024
Regen BioPharma, Inc. will be presenting at the Emerging Growth Conference on March 7, 2024.
March 5, 2024
·
3 min read
Policy
Cartesian Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Descartes-08 for the Treatment of Myasthenia Gravis
Cartesian Therapeutics, Inc., a clinical-stage biotechnology company pioneering mRNA cell therapy for autoimmune diseases, announced that the U.S. Food and Drug Administration has granted Regenerative Medicine Advanced Therapy designation for Descartes-08 for the treatment of myasthenia gravis.
May 22, 2024
·
6 min read
Press Releases
Regen BioPharma, Inc. to Present at the Emerging Growth Conference on September 25, 2024, At 4 pm Eastern Time
September 24, 2024
·
2 min read
Business
Cryoport and Minaris Regenerative Medicine Form Strategic Partnership to Support Advancement of Cell and Gene Therapies
Cryoport, Inc. and Minaris Regenerative Medicine Co., today announced a strategic partnership to provide fully integrated logistics and manufacturing services to biotechnology and pharmaceutical companies for regenerative medicine products to support the advancement of cell and gene therapies.
June 20, 2024
·
6 min read
Biotech Beach
Regen BioPharma, Inc. to Discuss Plans to Move Forward with HemaXellerate into Clinical Phase 1 at the Emerging Growth Conference on April 4, 2024
Regen BioPharma, Inc. (OTC PINK: RGBP) (OTC PINK: RGBPP), a biotechnology company advancing a diverse pre-clinical pipeline spanning cell therapies, RNA vaccines, RNA and DNA therapeutics and small molecule drugs will be presenting at the Emerging Growth Conference on April 4, 2024.
April 2, 2024
·
3 min read
Policy
TScan Therapeutics Receives FDA’s Regenerative Medicine Advanced Therapy (RMAT) Designation for its Two Lead TCR-T Therapy Candidates for the Treatment of Heme Malignancies
TScan Therapeutics, Inc. announced that the U.S. Food and Drug Administration has granted Regenerative Medicine Advanced Therapy designation to TSC-100 and TSC-101, the Company’s two lead TCR-T therapy candidates for the treatment of heme malignancies.
May 29, 2024
·
7 min read
Biotech Beach
Regen BioPharma, Inc. to Present at the Emerging Growth Conference on February 7, 2024
Regen BioPharma, Inc. (OTC PINK: RGBP) (OTC PINK: RGBPP), a biotechnology company advancing a diverse pre-clinical pipeline spanning cell therapies, RNA vaccines, RNA and DNA therapeutics and small molecule drugs will be presenting at the Emerging Growth Conference on February 7, 2024 (https://emerginggrowth.com/conference/).
February 5, 2024
·
3 min read
Biotech Beach
Lineage Receives Grant From California Institute for Regenerative Medicine (CIRM) - April 30, 2024
Lineage Cell Therapeutics, Inc. today announced that the Company has received an Education Conference II Grant from the California Institute for Regenerative Medicine (CIRM).
April 30, 2024
·
9 min read
1 of 69,782
Next
